Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Covid-19 crawled date : 2021 - 12 - 21 save search
Novavax Announces Initiation of PREVENT-19 COVID-19 Vaccine Phase 3 Trial Booster Study
Published: 2021-12-21 (Crawled : 23:00) - prnewswire.com
NVAX | $4.205 3.32% 3.21% 3.6M
|
Health Technology
|
| O: 0.11%
H: 1.0%
C: -4.17%
event-19 covid-19 trial covid vaccine phase 3
CDC Publishes AXIM® Biotechnologies-Sponsored Study on COVID-19 Neutralizing Antibodies
Published: 2021-12-21 (Crawled : 15:30) - biospace.com/
AXIM | $0.0127 -6.67% 720K
|
Manufacturing
|
| O: 1.94%
H: 4.13%
C: -6.67%
covid-19 axim covid pons biotech iot antibody
First-of-its-kind Cue Health Partnership with Air Canada Provides U.S.-based Customers with Special Access to the Most Accurate COVID-19 Self-Test
Published: 2021-12-21 (Crawled : 15:30) - prnewswire.com
HLTH | $0.15 6.38% 6.0% 230K
|
|
| O: 3.33%
H: 1.23%
C: -9.96%
covid-19 partnership health air covid test
CytoDyn Receives Positive Response From FDA in Regard to its Phase 3, Registrational Trial in COVID-19 Critically Ill Population
Published: 2021-12-21 (Crawled : 14:30) - biospace.com/
CYDY | $0.1501 0.06% 790K
|
Manufacturing
|
| O: 5.0%
H: 2.86%
C: 0.0%
covid-19 fda trial covid positive pons phase 3 response
Aridis Pharmaceuticals Announces a Pan-Coronavirus Monoclonal Antibody Cocktail That Retains Effectiveness Against the Omicron variant, other COVID-19 Variants, SARS, MERS, and the Common Cold Human Coronaviruses
Published: 2021-12-21 (Crawled : 11:00) - prnewswire.com
ARDS | $0.0645 2.82% 41K
|
Health Technology
|
| O: 60.24%
H: 6.63%
C: -31.7%
covid-19 als covid antibody
European Commission Expands Indication for Veklury (Remdesivir) for the Treatment of Adults Not on Supplemental Oxygen and Considered High Risk for COVID-19 Disease Progression
Published: 2021-12-21 (Crawled : 11:00) - biospace.com/
GILD | $67.03 0.12% 0.12% 5.2M
|
Health Technology
|
| O: 0.0%
H: 0.17%
C: -0.87%
covid-19 treatment europe risk oxygen covid disease
Gainers vs Losers
| 78% | 22% |
Top 10 Gainers
MTTR | News 4 | $4.6 164.37% 62.17% 28M
|
AGBA | $2.94 135.2% 57.48% 66M
|
Finance
EDBL | News | $6.46 71.81% 41.8% 2M
|
MTC | $2.25 44.23% 30.67% 6M
|
Technology Services
OPRT | News | $3.175 41.11% 29.13% 12M
|
Finance
SHIM | $3.05 35.56% 26.23% 1.1M
|
HKIT | $1.345 31.86% 24.16% 390K
|
Technology Services
ABVC | $1.36 30.77% 23.53% 7.4M
|
Wholesale Trade
OST | $0.512 28.0% 21.88% 290K
|
POET | $1.59 27.2% 21.38% 4.2M
|
Manufacturing
Your saved searches
Save your searches and get alerts when important news are released.